研究者業績

佐久間 康成

サクマ ヤスナル  (Yasunaru Sakuma)

基本情報

所属
自治医科大学 附属病院移植・再生医療センター 教授

通称等の別名
Yasunaru Sakuma
研究者番号
10296105
J-GLOBAL ID
202001003024187832
researchmap会員ID
R000014289

論文

 626
  • Kentaro Ushijima, Yukihiro Sanada, Shinya Otomo, Keiko Ogaki, Taiichi Wakiya, Noriki Okada, Yuta Hirata, Yasuharu Onishi, Yasunaru Sakuma, Yukiyo Wada, Akio Fujimura, Koichi Mizuta
    Clinical pharmacology and therapeutics 2025年3月16日  
    While endogenous cortisol secretion rises in the early morning, the number of lymphocytes in the blood is higher at night, thus exhibiting an antiphase pattern to cortisol secretion. Therefore, compared with the daytime, the infiltration of lymphocytes into immune-reactive tissues is enhanced at night. This study aimed to determine whether the administration of methylprednisolone (mPSL) in the evening is more effective against T cell-mediated rejection (TCMR) after liver transplantation compared with morning administration. This study used a randomized, open-label, parallel-group comparison design. Pediatric patients scheduled to undergo living-donor liver transplantation were randomly divided into morning (8:00 a.m.) and evening (8:00 p.m.) mPSL administration groups. The primary endpoint was the occurrence of TCMR within 14 days of surgery. Sixty-two patients were enrolled between 2014 and 2023, and six patients were excluded from the analysis as their dose of mPSL deviated from the protocol within 14 days after surgery. Of the 56 subjects analyzed, TCMR was detected in 10 of the morning group (n = 29) and three of the evening group (n = 27) within 14 days after surgery. Stratified analysis of patients who did not receive preoperative rituximab treatment showed that none of the evening group and 36.4% of the morning group developed TCMR within 14 days after surgery (P < 0.01, 95% confidence interval; 2.00-infinity). Safety evaluation results were comparable between the two groups. This study shows that the evening administration of mPSL is an effective approach for suppressing TCMR. This study is hypothesis generating, and replication in further studies is needed.
  • Kentaro Ushijima, Yukihiro Sanada, Shinya Otomo, Keiko Ogaki, Taiichi Wakiya, Noriki Okada, Yuta Hirata, Toshio Horiuchi, Takahiko Omameuda, Kiichiro Takadra, Ryosuke Akimoto, Yasuharu Onishi, Yasunaru Sakuma, Koichi Mizuta
    BMC infectious diseases 25(1) 97-97 2025年1月21日  
    BACKGROUND: Cytomegalovirus (CMV) is a major infectious complication in solid-organ transplant recipients, particularly in the context of pediatric liver transplantation. CMV serostatus is a well-established risk factor for postoperative CMV infection, with CMV seronegative recipients who receive organs from seropositive donors (D+/R-) being at the highest risk. Our previous research indicated a higher incidence of CMV infection in recipients with inherited metabolic diseases (IMDs) compared with those with biliary atresia (BA). This study aimed to determine whether IMDs constitute an independent risk factor for postoperative CMV infection. METHODS: We retrospectively analyzed data from 45 IMD and 230 BA recipients. We collected information on the occurrence and timing of episodes of CMV infections, methylprednisolone (mPSL) pulse therapy, patient characteristics, and peri- and postoperative data. RESULTS: Multivariable analysis identified mPSL pulse therapy (Odds Ratio (OR): 4.43), CMV serostatus (D+/R-) (OR: 6.03), and underlying IMDs (OR: 3.28) as independent risk factors for CMV infection. Further stratified analysis, which considered the timing of CMV infection diagnosis relative to mPSL pulse therapy, confirmed that CMV serostatus with (D+/R-) (OR: 5.61) and underlying IMDs (OR: 2.83) remained independent predictors of CMV infection, even when excluding the influence of mPSL pulse therapy. CONCLUSIONS: This study demonstrates that IMDs are a potent independent risk factor for CMV infection following pediatric liver transplantation. CLINICAL TRIAL NUMBER: Not applicable.
  • Yuta Hirata, Yasunaru Sakuma, Hideo Ogiso, Ryozo Nagai, Kenichi Aizawa
    Biomedicines 13(1) 2024年12月31日  
    Background: Even though many metabolic liver diseases can now be diagnosed using blood tests and diagnostic imaging, early diagnosis remains difficult. Understanding mechanisms contributing to the progression from Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Alcoholic Hepatitis (AH) to cirrhosis is critical to reduce the burden of end-stage liver disease. Monitoring individual bile acids has been proposed as a way to distinguish various liver disorders. Methods: This study explored bile acid profiles in patients with MASH and AH. Plasma samples from patients with MASH, AH, and a control group were analyzed using liquid chromatography-tandem mass spectrometry (LC-MS/MS) to quantify bile acid concentrations. Targeted metabolomic analysis was performed to compare bile acid levels between the hepatitis and control groups. Results: Concentrations of ursodeoxycholic acid (UDCA), chenodeoxycholic acid (CDCA), taurocholic acid (TCA), tauroursodeoxycholic acid (TUDCA), taurochenodeoxycholic acid (TCDCA), glycoursodeoxycholic acid (GUDCA), glycochenodeoxycholic acid (GCDCA), and glycocholic acid (GCA) were significantly elevated in the hepatitis group. Correlation analysis revealed strong positive relationships between the total and direct bilirubin levels and TUDCA and GCDCA. Aspartate aminotransferase (AST) showed strong positive correlations with TCDCA and GCDCA. Child-Pugh score, Fibrosis-4 index, and non-alcoholic fatty liver disease fibrosis score were positively correlated with GCA, whereas the aspartate aminotransferase-to-platelet ratio correlated with TCA, TCDCA, and GCA. The model for end-stage liver disease (MELD) score showed a strong positive correlation with GCDCA. Implications: GCDCA may serve as a predictive biomarker for liver damage, potentially enabling early diagnosis and targeted intervention in patients with MASH and AH.
  • Takahiko Omameuda, Yukihiro Sanada, Yasunaru Sakuma, Yasuharu Onishi, Taiichi Wakiya, Yuta Hirata, Toshio Horiuchi, Kiichiro Takadera, Ryosuke Akimoto, Naohiro Sata
    Clinical journal of gastroenterology 17(6) 1080-1086 2024年12月  
    Portal cavernoma cholangiopathy (PCC) is a complex condition associated with portal hypertension, particularly in patients with extrahepatic portal vein obstruction (EHPVO). Herein, we present a case of liver failure with PCC in a 55-year-old male successfully treated with living-donor liver transplantation (LDLT). The patient had a history of gastrointestinal bleeding and recurrence of cholangitis. Imaging studies confirmed cavernous transformation and pericholedochal varices. Preoperative angiography verified hepatopetal flow in the pericholedochal varix, which facilitated successful anastomosis with the donor's portal vein during LDLT. Histological examination of the explanted liver confirmed vanishing bile duct syndrome (VBDS) and secondary bile stasis was considered to have caused liver failure. No postoperative complications were observed within 13 months of LDLT. We report the first case of VBDS in the PCC resulting from EHPVO that was successfully managed with LDLT. Careful management of similar cases should involve angiography and long-term postoperative monitoring of portal vein complications.
  • Naoya Kasahara, Takumi Teratani, Junshi Doi, Shinichiro Yokota, Kentaro Shimodaira, Yuki Kaneko, Hideyuki Ohzawa, Yasunaru Sakuma, Hideki Sasanuma, Yasuhiro Fujimoto, Taizen Urahashi, Hideyuki Yoshitomi, Hironori Yamaguchi, Joji Kitayama, Naohiro Sata
    Stem cell research & therapy 15(1) 395-395 2024年11月4日  
    BACKGROUND: Globally, prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD) is increasing, and there is an urgent need to develop innovative therapies that promote liver regeneration following hepatectomy for this disease. Surgical excision is a key therapeutic approach with curative potential for liver tumors. However, hepatic steatosis can lead to delayed liver regeneration and higher post-operative complication risk. Mesenchymal stem cells-conditioned medium (MSC-CM) is considered a rich source of paracrine factors that can repair tissues and restore function of damaged organs. Meanwhile, hydrogels have been widely recognized to load MSC secretome and achieve sustained release. This study aimed to evaluate the therapeutic effect of hydrogel-encapsulated MSC-CM on liver regeneration following partial hepatectomy (PHx) in a rodent model of diet-induced hepatic steatosis. METHODS: Male Lewis rats were fed with a methionine and choline-deficient diet. After 3 weeks of feeding, PHx was performed and rats were randomly allocated into two groups that received hydrogel-encapsulated MSC-CM or vehicle via the intra-mesenteric space of the superior mesenteric vein (SMV). RESULTS: The regeneration of the remnant liver at 30 and 168 h after PHx was significantly accelerated, and the expressions of proliferating cell nuclear antigen were significantly enhanced in the MSC-CM group. MSC-CM treatment significantly increased hepatic ATP and β-hydroxybutyrate content at 168 h after PHx, indicating that MSC-CM fosters regeneration not only in volume but also in functionality. The number of each TUNEL- and cleaved caspase-3 positive nuclei in hepatocytes at 9 h after PHx were significantly decreased in the MSC-CM group, suggesting that MSC-CM suppressed apoptosis. MSC-CM increased serum immunoregulatory cytokine interleukin-10 and interleukin-13 at 30 h after PHx. Additionally, mitotic figures and cyclin D1 expression decreased and hepatocyte size increased in the MSC-CM group, implying that this mode of regeneration was mainly through cell hypertrophy rather than cell division. CONCLUSIONS: MSC-CM represents a novel therapeutic approach for patients with MASLD requiring PHx.
  • Hajime Uchida, Masato Shinkai, Hiroomi Okuyama, Takehisa Ueno, Mikihiro Inoue, Toshihiro Yasui, Eiso Hiyama, Sho Kurihara, Yasunaru Sakuma, Yukihiro Sanada, Akinobu Taketomi, Shohei Honda, Motoshi Wada, Ryo Ando, Jun Fujishiro, Mariko Yoshida, Yohei Yamada, Hiroo Uchida, Takahisa Tainaka, Mureo Kasahara
    Journal of pediatric surgery 59(9) 1791-1797 2024年9月  
    BACKGROUND: Although congenital portosystemic shunts (CPSSs) are increasingly being recognized, the optimal treatment strategies and natural prognosis remain unclear, as individual CPSSs show different phenotypes. METHODS: The medical records of 122 patients who were diagnosed with CPSSs at 15 participating hospitals in Japan between 2000 and 2019 were collected for a retrospective analysis based on the state of portal vein (PV) visualization on imaging. RESULTS: Among the 122 patients, 75 (61.5%) showed PV on imaging. The median age at the diagnosis was 5 months. The main complications related to CPSS were hyperammonemia (85.2%), liver masses (25.4%), hepatopulmonary shunts (13.9%), and pulmonary hypertension (11.5%). The prevalence of complications was significantly higher in patients without PV visualization than in those with PV visualization (P < 0.001). Overall, 91 patients (74.6%) received treatment, including shunt closure by surgery or interventional radiology (n = 82) and liver transplantation (LT) or liver resection (n = 9). Over the past 20 years, there has been a decrease in the number of patients undergoing LT. Although most patients showed improvement or reduced progression of symptoms, liver masses and pulmonary hypertension were less likely to improve after shunt closure. Complications related to shunt closure were more likely to occur in patients without PV visualization (P = 0.001). In 25 patients (20.5%) without treatment, those without PV visualization were significantly more likely to develop complications related to CPSS than those with PV visualization (P = 0.011). CONCLUSION: Patients without PV visualization develop CPSS-related complications and, early treatment using prophylactic approaches should be considered, even if they are asymptomatic. LEVEL OF EVIDENCE: Level III.
  • 下平 健太郎, 笹沼 英紀, 木村 有希, 青木 裕一, 目黒 由行, 田口 昌延, 森嶋 計, 佐久間 康成, 北山 丈二, 佐田 尚宏
    膵臓 39(3) A340-A340 2024年7月  
  • 田口 昌延, 笹沼 英紀, 下平 健太郎, 青木 裕一, 目黒 由行, 森嶋 計, 宮戸 秀世, 大澤 英之, 遠藤 和洋, 山口 博紀, 佐久間 康成, 佐田 尚宏
    膵臓 39(3) A346-A346 2024年7月  
  • 高橋 礼, 齋藤 晶, 木村 有希, 青木 裕一, 田口 昌延, 森嶋 計, 宮戸 秀世, 大澤 英之, 遠藤 和洋, 笹沼 英紀, 山口 博紀, 佐久間 康成, 川平 洋, 堀江 久永, 細谷 好則, 味村 俊樹, 北山 丈二, 佐田 尚宏
    膵臓 39(3) A373-A373 2024年7月  
  • 森嶋 計, 木村 有希, 青木 裕一, 目黒 由行, 笠原 尚哉, 遠藤 和洋, 笹沼 英紀, 佐久間 康成, 山口 博紀, 北山 丈二, 佐田 尚宏
    膵臓 39(3) A394-A394 2024年7月  
  • 篠田 祐之, 田口 昌延, 下平 健太郎, 木村 有希, 青木 裕一, 目黒 由行, 森嶋 計, 宮戸 秀世, 大澤 英之, 遠藤 和洋, 笹沼 英紀, 山口 博紀, 佐久間 康成, 佐田 尚宏
    膵臓 39(3) A466-A466 2024年7月  
  • 木村 有希, 笹沼 英紀, 青木 裕一, 森嶋 計, 遠藤 和洋, 佐久間 康成, 堀江 久永, 細谷 好則, 北山 丈二, 山口 博紀, 佐田 尚宏
    膵臓 39(3) A488-A488 2024年7月  
  • 利府 数馬, 笹沼 英紀, 木村 有希, 青木 裕一, 田口 昌延, 森嶋 計, 遠藤 和洋, 佐久間 康成, 堀江 久永, 細谷 好則, 山口 博紀, 北山 丈二, 佐田 尚宏
    膵臓 39(3) A489-A489 2024年7月  
  • Takehiro Kagaya, Atsushi Miki, Jun Watanabe, Rihito Kanamaru, Shiro Matsumoto, Kentaro Kurashina, Shin Saito, Takumi Teratani, Yoshinori Hosoya, Yasunaru Sakuma, Joji Kitayama, Naohiro Sata
    World Journal of Surgery 2024年6月24日  
    Abstract Background Osteopenia reflects frailty and has been shown to be associated with outcomes in cancer patients. This study was undertaken to examine whether osteopenia is an independent prognostic factor in patients with esophageal cancer after resection. Methods A total of 214 patients who underwent surgery for esophageal cancer were analyzed retrospectively. Bone mineral density (BMD) of the 11th thoracic vertebra was measured by computed tomography scan, and patients classified into osteopenia and normal BMD groups with BMD &lt;160 Hounsfield units as the cutoff. Clinicopathological data and prognosis were analyzed. Results The 5‐year survival rate was 55.4% for the osteopenia group and 74.7% for the normal BMD group with a significantly worse prognosis in the osteopenia group (p = 0.0080). In multivariable analysis, osteopenia was a significant independent risk factor associated with overall survival (hazard ratio [HR] 1.90, 95% confidence interval [CI] 1.27–3.34, and p = 0.0151) along with R1/2 resection (HR 3.02, 95% CI 1.71–5.18, and p = 0.0002). Conclusion In patients with esophageal cancer undergoing resection, osteopenia may be a surrogate marker for frailty and an independent predictor of prognosis.
  • Takahiko Omameuda, Taiichi Wakiya, Yasunaru Sakuma, Yasuharu Onishi, Toshiyuki Yamada, Katsutoshi Takanami, Yukihiro Sanada, Yuta Hirata, Toshio Horiuchi, Naohiro Sata
    Transplantation proceedings 56(5) 1148-1152 2024年6月  
    Alanine aminotransferase (ALT) is an enzyme that catalyzes the transfer of amino groups from alanine to ketoglutaric acid. ALT is an established marker of liver diseases. Occasionally, ALT levels may be abnormally low due to various factors, making accurate assessment difficult. To date, no studies have documented ALT alterations following Living donor liver transplantation (LDLT) in patients with low ALT levels. Here, we present a case of abnormally low ALT levels that were ameliorated by LDLT. A 27-year-old woman underwent LDLT for refractory cholangitis with biliary atresia. The patient's preoperative ALT level was 1 IU/L. Following graft reperfusion, ALT levels increased (peak value, 456 IU/L), primarily attributed to the donor liver. After LDLT, ALT levels consistently surpassed the lower limit. The differential diagnosis of abnormally low ALT levels suggested a genetic mutation as the most probable underlying cause. Even after LDLT, ALT levels in organs other than the transplanted liver would remain abnormally low. Therefore, to prevent underestimating liver damage, the standard ALT range for such cases should be set lower than the typical range.
  • Takashi Ishida, Atsushi Miki, Yasunaru Sakuma, Jun Watanabe, Kazuhiro Endo, Hideki Sasanuma, Takumi Teratani, Joji Kitayama, Naohiro Sata
    Cancers 16(11) 2087-2087 2024年5月30日  
    Background: Osteopenia is a well-known risk factor for survival in patients with hepatocellular carcinoma; however, it is unclear whether osteopenia can apply to both genders and how osteopenia is associated with cancer progression. The aim of this study was to elucidate whether osteopenia predicts reduced survival in regression models in both genders and whether osteopenia is associated with the pathological factors associated with reduced survival. Methods: This study included 188 consecutive patients who underwent hepatectomy. Bone mineral density was assessed using computed tomography (CT) scan images taken within 3 months before surgery. Non-contrast CT scan images at the level of the 11th thoracic vertebra were used. The cutoff value of osteopenia was calculated using a threshold value of 160 Hounsfield units. Overall survival (OS) curves and recurrence-free survival (RFS) were constructed using the Kaplan–Meier method, as was a log-rank test for survival. The hazard ratio and 95% confidence interval for overall survival were calculated using Cox’s proportional hazard model. Results: In the regression analysis, age predicted bone mineral density. The association in females was greater than that in males. The OS and RFS of osteopenia patients were shorter than those for non-osteopenia patients. According to univariate and multivariate analyses, osteopenia was an independent risk factor for OS and RFS. The sole pathological factor associated with osteopenia was microvascular portal vein invasion. Conclusion: Models suggest that osteopenia may predict decreased OS and RFS in patients undergoing resection of hepatocellular carcinoma due to the mechanisms mediated via microvascular portal vein invasion.
  • 兼田 裕司, 木村 有希, 齋藤 晶, 金子 勇貴, 高橋 礼, 青木 裕一, 目黒 由行, 田口 昌延, 森嶋 計, 笹沼 英紀, 佐久間 康成, 川平 洋, 堀江 久永, 細谷 好則, 味村 俊樹, 山口 博紀, 北山 丈二, 佐田 尚宏
    日本外科学会定期学術集会抄録集 124回 SDGs-7 2024年4月  
  • 太田 学, 堀江 久永, 村橋 賢, 利府 数馬, 本間 祐子, 津久井 秀則, 東條 峰之, 佐田友 藍, 森 和亮, 鯉沼 広治, 山口 博紀, 佐久間 康成, 川平 洋, 細谷 好則, 味村 俊樹, 北山 丈二, 佐田 尚宏
    日本外科学会定期学術集会抄録集 124回 SY-5 2024年4月  
  • 木村 究, 上村 博輝, 渡邉 雄介, 五十嵐 聡, 土屋 淳紀, 寺井 崇二, 佐久間 康成, 大西 康晴, 眞田 幸弘, 脇屋 太一, 平田 雄大, 大豆生田 尚彦
    肝臓 65(Suppl.1) A301-A301 2024年4月  
  • Taiichi Wakiya, Yasunaru Sakuma, Yasuharu Onishi, Yukihiro Sanada, Noriki Okada, Yuta Hirata, Toshio Horiuchi, Takahiko Omameuda, Kiichiro Takadera, Naohiro Sata
    Scientific reports 14(1) 6753-6753 2024年3月21日  
    The liver and pancreas work together to recover homeostasis after hepatectomy. This study aimed to investigate the effect of liver resection volume on the pancreas. We collected clinical data from 336 living liver donors. They were categorized into left lateral sectionectomy (LLS), left lobectomy, and right lobectomy (RL) groups. Serum pancreatic enzymes were compared among the groups. Serum amylase values peaked on postoperative day (POD) 1. Though they quickly returned to preoperative levels on POD 3, 46% of cases showed abnormal values on POD 7 in the RL group. Serum lipase levels were highest at POD 7. Lipase values increased 5.7-fold on POD 7 in the RL group and 82% of cases showed abnormal values. The RL group's lipase was twice that of the LLS group. A negative correlation existed between the remnant liver volume and amylase (r = - 0.326)/lipase (r = - 0.367) on POD 7. Furthermore, a significant correlation was observed between POD 7 serum bilirubin and amylase (r = 0.379)/lipase (r = 0.381) levels, indicating cooccurrence with liver and pancreatic strain. Pancreatic strain due to hepatectomy occurs in a resection/remnant liver volume-dependent manner. It would be beneficial to closely monitor pancreatic function in patients undergoing a major hepatectomy.
  • Naoya Kasahara, Takumi Teratani, Shinichiro Yokota, Yasunaru Sakuma, Hideki Sasanuma, Yasuhiro Fujimoto, Tetsuo Ijichi, Taizen Urahashi, Hideyuki Yoshitomi, Joji Kitayama, Naohiro Sata
    Scientific Reports 14(1) 2024年2月26日  
    Abstract Intestinal adaptation does not necessarily recover absorptive capacity in short bowel syndrome (SBS), sometimes resulting in intestinal failure-associated liver disease (IFALD). Additionally, its therapeutic options remain limited. Polyamines (spermidine and spermine) are known as one of the autophagy inducers and play important roles in promoting the weaning process; however, their impact on intestinal adaptation is unknown. The aim of this study was to investigate the impact of polyamines ingestion on adaptation and hepatic lipid metabolism in SBS. We performed resection of two-thirds of the small intestine in male Lewis rats as an SBS model. They were allocated into three groups and fed different polyamine content diets (0%, 0.01%, 0.1%) for 30 days. Polyamines were confirmed to distribute to remnant intestine, whole blood, and liver. Villous height and number of Ki-67-positive cells in the crypt area increased with the high polyamine diet. Polyamines increased secretory IgA and mucin content in feces, and enhanced tissue Claudin-3 expression. In contrast, polyamines augmented albumin synthesis, mitochondrial DNA copy number, and ATP storage in the liver. Moreover, polyamines promoted autophagy flux and activated AMP-activated protein kinase with suppression of lipogenic gene expression. Polyamines ingestion may provide a new therapeutic option for SBS with IFALD.
  • 大友 慎也, 大柿 景子, 笹原 鉄平, 佐久間 康成, 大西 康晴, 眞田 幸弘, 脇屋 太一, 平田 雄大, 大豆生田 尚彦, 高寺 樹一朗, 今井 靖
    日本化学療法学会雑誌 72(1) 93-93 2024年1月  
  • 大柿 景子, 大友 慎也, 佐久間 康成, 大西 康晴, 眞田 幸弘, 脇屋 太一, 平田 雄大, 大豆生田 尚彦, 吉田 幸世, 関谷 菜津美, 今井 靖
    日本化学療法学会雑誌 72(1) 106-106 2024年1月  
  • Takumi Teratani, Yasuhiro Fujimoto, Yasunaru Sakuma, Naoya Kasahara, Masashi Maeda, Atsushi Miki, Alan Kawarai Lefor, Naohiro Sata, Joji Kitayama
    Transplant international : official journal of the European Society for Organ Transplantation 37 11336-11336 2024年  
    Segmental grafts from living donors have advantages over grafts from deceased donors when used for small intestine transplantation. However, storage time for small intestine grafts can be extremely short and optimal graft preservation conditions for short-term storage remain undetermined. Secreted factors from mesenchymal stem cells (MSCs) that allow direct activation of preserved small intestine grafts. Freshly excised Luc-Tg LEW rat tissues were incubated in preservation solutions containing MSC-conditioned medium (MSC-CM). Preserved Luc-Tg rat-derived grafts were then transplanted to wild-type recipients, after which survival, injury score, and tight junction protein expression were examined. Luminance for each graft was determined using in vivo imaging. The findings indicated that 30-100 and 3-10 kDa fractions of MSC-CM have superior activating effects for small intestine preservation. Expression of the tight-junction proteins claudin-3, and zonula occludens-1 preserved for 24 h in University of Wisconsin (UW) solution containing MSC-CM with 50-100 kDa, as shown by immunostaining, also indicated effectiveness. Reflecting the improved graft preservation, MSC-CM preloading of grafts increased survival rate from 0% to 87%. This is the first report of successful transplantation of small intestine grafts preserved for more than 24 h using a rodent model to evaluate graft preservation conditions that mimic clinical conditions.
  • 平田 雄大, 眞田 幸弘, 大西 康晴, 岡田 憲樹, 堀内 俊男, 大豆生田 尚彦, 佐久間 康成, 佐田 尚宏
    日本小児外科学会雑誌 59(7) 1058-1063 2023年12月  
    腸管重積型逆流防止弁付加手術を行った胆道閉鎖症(BA)において,挙上空腸狭窄が難治性胆管炎の契機となり,生体肝移植(LDLT)を施行した2例を報告する.【症例1】15歳女児.生後1ヵ月時にBAに対して肝門部空腸吻合術を施行したが,胆汁排泄不良で生後2ヵ月時に逆流防止弁付き再吻合術を施行した.術後15年時に挙上空腸狭窄による難治性胆管炎に対してイレウス管を留置したが,肝内胆管数珠状拡張と黄疸は改善せず,LDLTを施行した.【症例2】26歳男性.生後4ヵ月時にBAに対して逆流防止弁付き肝門部空腸吻合術を施行した.術後25年時に黄疸を伴う胆管炎が出現したため,挙上空腸狭窄に対してENBDチューブを留置したが,胆管炎は改善せず,LDLTを施行した.逆流防止弁は長期BAにおいて挙上空腸狭窄による難治性胆管炎の原因になることがある.(著者抄録)
  • 木村 有希, 田口 昌延, 小堀 篤也, 青木 裕一, 森嶋 計, 笹沼 英紀, 佐久間 康成, 山口 博紀, 堀江 久永, 細谷 好則, 味村 俊樹, 北山 丈二, 佐野 直樹, 福嶋 敬宣, 佐田 尚宏
    日本臨床外科学会雑誌 84(増刊) S394-S394 2023年10月  
  • 山田 百合子, 田口 昌延, 谷口 理丈, 森嶋 計, 天野 雄介, 福嶋 敬宜, 遠藤 和洋, 笹沼 英紀, 佐久間 康成, 細谷 好則, 堀江 久永, 山口 博紀, 味村 俊樹, 北山 丈二, 佐田 尚宏
    日本臨床外科学会雑誌 84(増刊) S462-S462 2023年10月  
  • 藤沼 香栄, 田口 昌延, 下平 健太郎, 森嶋 計, 三木 厚, 兼田 裕司, 遠藤 和洋, 笹沼 英紀, 佐久間 康成, 細谷 好則, 堀江 久永, 山口 博紀, 味村 俊樹, 北山 丈二, 佐田 尚宏
    日本臨床外科学会雑誌 84(増刊) S515-S515 2023年10月  
  • 堀内 俊男, 眞田 幸弘, 高寺 樹一朗, 大豆生田 尚彦, 平田 雄大, 岡田 憲樹, 脇屋 太一, 大西 康晴, 三谷 忠宏, 熊谷 秀規, 佐久間 康成, 佐田 尚宏
    日本小児栄養消化器肝臓学会雑誌 37(Suppl.) 86-86 2023年10月  
  • Atsushi Miki, Yasunaru Sakuma, Jun Watanabe, Kazuhiro Endo, Hideki Sasanuma, Takumi Teratani, Alan Kawarai Lefor, Atsushi Shimizu, Joji Kitayama, Yoshikazu Yasuda, Naohiro Sata
    Scientific Reports 13(1) 2023年9月20日  
    Abstract It is important to assess the prognosis and intervene before and after surgery in patients with hepatocellular carcinoma. This study aims to elucidate the association of outcomes and residual liver function after hepatectomy. A total of 176 patients who underwent the initial resection for hepatocellular carcinoma between January 2011 and March 2021 at Jichi Medical University were included. Hepatic clearance of the remnant liver was measured using 99mTc-galactosyl serum albumin scintigraphy. The log-rank test was used to analyze survival using the Kaplan–Meier method. Hazard ratios (HR) and 95% confidence intervals (CI) for overall survival were calculated using Cox’s proportional hazard model. In multivariate analysis, microvascular invasion, intraoperative blood loss, and hepatic clearance of the remnant liver were independently associated with overall survival. Hepatic clearance of the remnant liver was independently associated with recurrence free survival. This is the first report to show that lower residual liver function is associated with shorter survival in patients with hepatocellular carcinoma undergoing hepatectomy. Preoperative determination of remnant liver function may allow assessment of prognosis in patients planned to undergo resection of hepatocellular carcinoma. Preservation of liver functional reserve may be crucial for improved long-term outcomes after hepatectomy.
  • Kiri Koshu, Kazuhiro Muramatsu, Tomomi Maru, Yoshie Kurokawa, Yoshitaka Mizobe, Hirokazu Yamagishi, Daisuke Matsubara, Koji Yokoyama, Eriko Jimbo, Hideki Kumagai, Yukihiro Sanada, Yasunaru Sakuma, Noriyoshi Fukushima, Aya Narita, Takanori Yamagata, Hitoshi Osaka
    Brain & development 45(9) 517-522 2023年7月8日  
    BACKGROUND: Niemann-Pick disease type C (NPC) is an autosomal recessive inherited and neurodegenerative disorder. Approximately 10% of NPC patients have acute liver failure and sometimes need liver transplantation (LT), and 7% reportedly develop inflammatory bowel disease (IBD). We report the case of a girl with NPC who had a re- accumulation of cholesterol in the transplanted liver and NPC-related IBD. CASE REPORT: The patient underwent living donor liver transplantation (LDLT) due to severe acute liver failure caused by an unknown etiology inherited from her father. At 1 year and 6 months (1Y6M), she developed neurological delay, catalepsy, and vertical supranuclear gaze palsy. The foam cells were found in her skin, and fibroblast Filipin staining was positive; hence, she was diagnosed with NPC. It was identified that her father had NPC heterozygous pathogenic variant. At 2 years, she had anal fissure, skin tag and diarrhea. She was diagnosed with NPC-related IBD, using a gastrointestinal endoscopy. Three years after LT, liver biopsy revealed foam cells and numerous fatty droplets. At 8 years, broken hepatocytes and substantial fibrosis were observed. She died from circulation failure due to hypoalbuminemia at 8Y2M. CONCLUSIONS: In NPC, load of cholesterol metabolism is suggested to persist even after LT. LDLT from NPC heterozygous variant donor was insufficient to metabolize cholesterol overload. In NPC patients, the possibility of cholesterol re-accumulation should be considered when LT is performed. NPC-related IBD should be considered when NPC patients have anorectal lesions or diarrhea.
  • 森嶋 計, 下平 健太郎, 青木 裕一, 田口 昌延, 遠藤 和洋, 笹沼 英紀, 佐久間 康成, 福嶋 敬宜, 佐田 尚宏
    膵臓 38(3) A464-A464 2023年7月  
  • 藤沼 香栄, 田口 昌延, 下平 健太郎, 青木 裕一, 目黒 由行, 森嶋 計, 三木 厚, 宮戸 秀世, 大澤 英之, 兼田 裕司, 遠藤 和洋, 小泉 大, 吉田 淳, 笹沼 英紀, 山口 博紀, 佐久間 康成, 北山 丈二, 佐田 尚宏
    膵臓 38(3) A392-A392 2023年7月  
  • 田口 昌延, 笹沼 英紀, 下平 健太郎, 青木 裕一, 目黒 由行, 森嶋 計, 三木 厚, 宮戸 秀世, 大澤 英之, 兼田 裕司, 遠藤 和洋, 小泉 大, 吉田 淳, 山口 博紀, 佐久間 康成, 北山 丈二, 佐田 尚宏
    膵臓 38(3) A405-A405 2023年7月  
  • 森嶋 計, 下平 健太郎, 青木 裕一, 田口 昌延, 遠藤 和洋, 笹沼 英紀, 佐久間 康成, 福嶋 敬宜, 佐田 尚宏
    膵臓 38(3) A464-A464 2023年7月  
  • 眞田 幸弘, 佐久間 康成, 大西 康晴, 脇屋 太一, 岡田 憲樹, 平田 雄大, 堀内 俊男, 片野 匠, 大豆生田 尚彦, 高寺 樹一朗, 関谷 菜津美, 吉田 幸世, 佐田 尚宏
    小児外科 55(6) 609-617 2023年6月  
  • 平田 雄大, 眞田 幸弘, 大西 康晴, 脇屋 太一, 岡田 憲樹, 堀内 俊男, 大豆生田 尚彦, 高寺 樹一朗, 佐久間 康成, 佐田 尚宏
    小児外科 55(6) 654-659 2023年6月  
  • 田口 昌延, 笹沼 英紀, 下平 健太郎, 森嶋 計, 三木 厚, 宮戸 秀世, 吉田 淳, 大澤 英之, 兼田 裕司, 遠藤 和洋, 小泉 大, 山口 博紀, 佐久間 康成, 北山 丈二, 佐田 尚宏
    日本胆膵病態・生理研究会プログラム・抄録集 40回 24-24 2023年6月  
  • 笹沼 英紀, 佐田 尚宏, 下平 健太郎, 青木 裕一, 田口 昌延, 森嶋 計, 三木 厚, 遠藤 和洋, 小泉 大, 吉田 淳, 佐久間 康成, 北山 丈二
    日本外科系連合学会誌 48(3) 289-289 2023年5月  
  • 笹沼 英紀, 伊澤 祥光, 佐久間 康成, 堀江 久永, 細谷 好則, 間藤 卓, 布宮 伸, 瓦井Lefor Alan, 北山 丈二, 佐田 尚宏
    日本腹部救急医学会雑誌 43(4) 707-713 2023年5月  
  • 太田 学, 堀江 久永, 宮原 悠三, 本間 祐子, 太白 健一, 佐田友 藍, 田原 真紀子, 井上 賢之, 鯉沼 広治, 山口 博紀, 佐久間 康成, 川平 洋, 細谷 好則, 味村 俊樹, 北山 丈二, 佐田 尚宏
    日本外科学会定期学術集会抄録集 123回 PD-6 2023年4月  
  • 兼田 裕司, 木村 有希, 齋藤 晶, 小泉 大, 笹沼 英紀, 山口 博紀, 佐久間 康成, 川平 洋, 堀江 久永, 細谷 好則, 味村 俊樹, 北山 丈二, 佐田 尚宏
    日本外科学会定期学術集会抄録集 123回 HFT-3 2023年4月  
  • 兼田 裕司, 木村 有希, 齋藤 晶, 小泉 大, 笹沼 英紀, 山口 博紀, 佐久間 康成, 川平 洋, 堀江 久永, 細谷 好則, 味村 俊樹, 北山 丈二, 佐田 尚宏
    日本外科学会定期学術集会抄録集 123回 HFT-3 2023年4月  
  • 清水 敦, 野田 泰子, 佐久間 康成, 大西 康晴, 笹沼 英紀, 堀江 久永, 細谷 好則, 北山 丈二, 佐田 尚宏
    日本外科学会定期学術集会抄録集 123回 SF-4 2023年4月  
  • 大西 康晴, 佐久間 康成, 眞田 幸弘, 脇屋 太一, 岡田 憲樹, 平田 雄大, 堀内 俊男, 大豆生田 尚彦, 水田 耕一, 佐田 尚宏
    日本外科学会定期学術集会抄録集 123回 DP-6 2023年4月  
  • 眞田 幸弘, 佐久間 康成, 大西 康晴, 脇屋 太一, 岡田 憲樹, 平田 雄大, 堀内 俊男, 片野 匠, 大豆生田 尚彦, 佐田 尚宏
    日本外科学会定期学術集会抄録集 123回 DP-8 2023年4月  
  • Atsushi Miki, Yasunaru Sakuma, Jun Watanabe, Kazuhiro Endo, Hideki Sasanuma, Takumi Teratani, Alan Kawarai Lefor, Joji Kitayama, Naohiro Sata
    Current Oncology 30(2) 1860-1868 2023年2月2日  
    Background: The prognostic importance of osteopenia in patients with intrahepatic cholangiocarcinoma (ICC) undergoing hepatectomy is unclear. The aim of this study was to evaluate the impact of osteopenia on survival in patients with ICC. Methods: A total of 71 patients who underwent hepatectomy at Jichi Medical University between July 2008 and June 2022 were included in this study. Non-contrast computed tomography scan images at the eleventh thoracic vertebra were used to assess bone mineral density. The cutoff value was calculated using a threshold value of 160 Hounsfield units. Overall survival curves were made using the Kaplan–Meier method and the log-rank test was used to evaluate survival. The hazard ratio (HR) and 95% confidence interval (CI) for overall survival were calculated using Cox’s proportional hazard model. Results: In multivariable analysis, osteopenia (HR 3.66, 95%CI 1.16–14.1, p = 0.0258) and the platelet–lymphocyte ratio (HR 6.26, 95%CI 2.27–15.9, p = 0.0008) were significant independent factors associated with overall survival. There were no significant independent prognostic factors for recurrence-free survival. Conclusions: Preoperative osteopenia is significantly associated with postoperative survival in patients with ICC undergoing hepatectomy.
  • 田中 保平, 太田 学, 宮戸 秀世, 本間 祐子, 太白 健一, 佐田友 藍, 田原 真紀子, 鯉沼 広治, 笹沼 英紀, 山口 博紀, 佐久間 康成, 川平 洋, 堀江 久永, 細谷 好則, 味村 俊樹, 北山 丈二, 佐田 尚宏
    日本腹部救急医学会雑誌 43(2) 469-469 2023年2月  
  • 窪木 大悟, 太田 学, 金丸 理人, 倉科 憲太郎, 鯉沼 広治, 笹沼 英紀, 山口 博紀, 佐久間 康成, 川平 洋, 堀江 久永, 細谷 好則, 味村 俊樹, 北山 丈二, 佐田 尚宏
    日本腹部救急医学会雑誌 43(2) 566-566 2023年2月  
  • 平田 雄大, 眞田 幸弘, 大西 康晴, 脇屋 太一, 岡田 憲樹, 堀内 俊男, 大豆生田 尚彦, 佐久間 康成, 佐田 尚宏
    日本小児外科学会雑誌 59(1) 149-149 2023年2月  

MISC

 134

書籍等出版物

 2

共同研究・競争的資金等の研究課題

 11